Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Nielsen

Showing results (771-780 of 839) with videos related to

Pageof 84
Sort By:
Scientific Reports|April 30, 2021
KLK3 SNP-SNP interactions for prediction of prostate cancer aggressivenessHui-Yi Lin, Po-Yu Huang, Chia-Ho Cheng, et al.
Science (New York, N.Y.)|March 12, 2016
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart diseasePaolo Zanoni, Sumeet A Khetarpal, Daniel B Larach, et al.
Communications Medicine|May 27, 2026
Polygenic risk score with KLK3 SNP-SNP interaction pairs for predicting prostate cancer aggressivenessHui-Yi Lin, Indrani Sarkar, Harun Mazumder, et al.
Genome Research|May 6, 2011
Comparative genomics of citric-acid-producing Aspergillus niger ATCC 1015 versus enzyme-producing CBS 513.88Mikael R Andersen, Margarita P Salazar, Peter J Schaap, et al.
Plos One|April 10, 2014
Susceptibility to chronic mucus hypersecretion, a genome wide association studyAkkelies E Dijkstra, Joanna Smolonska, Maarten van den Berge, et al.
European Journal of Preventive Cardiology|December 13, 2016
Genetic invalidation of Lp-PLA<sub>2</sub> as a therapeutic target: Large-scale study of five functional Lp-PLA<sub>2</sub>-lowering allelesJohn M Gregson, Daniel F Freitag, Praveen Surendran, et al.
BMJ (Clinical Research Ed.)|January 12, 2018
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohortsTyler M Seibert, Chun Chieh Fan, Yunpeng Wang, et al.
Cancers|November 7, 2020
The <i>CHEK2</i> Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common AncestorAndreia Brandão, Paula Paulo, Sofia Maia, et al.
Prostate Cancer and Prostatic Diseases|January 9, 2021
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Nature Cancer|January 26, 2026
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS studyJason L Vassy, Anna M Dornisch, Roshan Karunamuni, et al.
Pageof 84

Showing results (771-780 of 839) with videos related to

Sort By:
Pageof 84
Scientific Reports|April 30, 2021
KLK3 SNP-SNP interactions for prediction of prostate cancer aggressivenessHui-Yi Lin, Po-Yu Huang, Chia-Ho Cheng, et al.
Science (New York, N.Y.)|March 12, 2016
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart diseasePaolo Zanoni, Sumeet A Khetarpal, Daniel B Larach, et al.
Communications Medicine|May 27, 2026
Polygenic risk score with KLK3 SNP-SNP interaction pairs for predicting prostate cancer aggressivenessHui-Yi Lin, Indrani Sarkar, Harun Mazumder, et al.
Genome Research|May 6, 2011
Comparative genomics of citric-acid-producing Aspergillus niger ATCC 1015 versus enzyme-producing CBS 513.88Mikael R Andersen, Margarita P Salazar, Peter J Schaap, et al.
Plos One|April 10, 2014
Susceptibility to chronic mucus hypersecretion, a genome wide association studyAkkelies E Dijkstra, Joanna Smolonska, Maarten van den Berge, et al.
European Journal of Preventive Cardiology|December 13, 2016
Genetic invalidation of Lp-PLA<sub>2</sub> as a therapeutic target: Large-scale study of five functional Lp-PLA<sub>2</sub>-lowering allelesJohn M Gregson, Daniel F Freitag, Praveen Surendran, et al.
BMJ (Clinical Research Ed.)|January 12, 2018
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohortsTyler M Seibert, Chun Chieh Fan, Yunpeng Wang, et al.
Cancers|November 7, 2020
The <i>CHEK2</i> Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common AncestorAndreia Brandão, Paula Paulo, Sofia Maia, et al.
Prostate Cancer and Prostatic Diseases|January 9, 2021
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Nature Cancer|January 26, 2026
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS studyJason L Vassy, Anna M Dornisch, Roshan Karunamuni, et al.
Pageof 84